|
|
||||||||




* Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, the Ohio State University, Wooster, Ohio 44691;
Laboratory of Persistent Viral Infections, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840;
Department of Physiology and Biophysics;
Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011; || AccuDx Inc., San Diego, California 92126; and ¶ Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106
To whom requests for reprints should be addressed at 1 Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, 1365 Gortner Avenue, 225 VTH, St. Paul, MN 55108. E-mail: sreev001{at}umn.edu
DNA aptamers were selected against recombinant human (rhu) cellular prion protein (PrPC) 23231 by systematic evolution of ligands via a systematic evolution of ligands by exponential (SELEX) enrichment procedure using lateral flow chromatography. The SELEX procedure was performed with an aptamer library consisting of a randomized 40-nucleotide core flanked by 28-mer primer-binding sites that, theoretically, represented approximately 1024 distinct nucleic acid species. Sixty nanograms of rhuPrPC23231 immobilized in the center of a lateral flow device was used as the target molecule for SELEX. At the end of 6 iterations of SELEX, 13 distinct candidate aptamers were identified, of which, 3 aptamers represented 32%, 8%, and 5% of the sequences respectively. Eight aptamers, including the three most frequently occurring candidates, were selected for further evaluation. Selected aptamers bound to rhuPrPC23231 at 106 M to 108 M concentrations. Two of the eight aptamers bound at higher concentrations to rhuPrPC90231. Theoretical thermodynamic modeling of selected aptamer sequences identified several common motifs among the selected aptamers that could play a role in PrP binding. Binding affinity to rhuPrPC23231 was both aptamer sequence and structure dependent. Further, selected aptamers bound to mammalian PrPs derived from brain of healthy sheep, calf, piglet, and deer, and to PrPC expressed in mouse neuroblastoma cells. None of the aptamers bound to proteinase Kdigested scrapie-infected mouse neuroblastoma cells or untreated PrP-null cells, which further confirmed the PrPC specificity of the aptamers. In summary, we enriched and selected DNA aptamers that bind specifically to rhuPrPC and mammalian PrPC with varying affinities and can be applied to biological samples for PrPC enrichment and as diagnostic tools in double ligand assay systems.
Key Words: DNA aptamers prion scrapie TSE
This article has been cited by other articles:
![]() |
M. P. B. Gomes, T. A. Millen, P. S. Ferreira, N. L. C. e Silva, T. C. R. G. Vieira, M. S. Almeida, J. L. Silva, and Y. Cordeiro Prion Protein Complexed to N2a Cellular RNAs through Its N-terminal Domain Forms Aggregates and Is Toxic to Murine Neuroblastoma Cells J. Biol. Chem., July 11, 2008; 283(28): 19616 - 19625. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Lee, L. D. Raymond, B. Schoen, G. J. Raymond, L. Kett, R. A. Moore, L. M. Johnson, L. Taubner, J. O. Speare, H. A. Onwubiko, et al. Hemin Interactions and Alterations of the Subcellular Localization of Prion Protein J. Biol. Chem., December 14, 2007; 282(50): 36525 - 36533. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Choi, V. Anantharam, N. J. Saetveit, R. S. Houk, A. Kanthasamy, and A. G. Kanthasamy Normal Cellular Prion Protein Protects against Manganese-Induced Oxidative Stress and Apoptotic Cell Death Toxicol. Sci., August 1, 2007; 98(2): 495 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Bannantine, T. J. Radosevich, J. R. Stabel, S. Sreevatsan, V. Kapur, and M. L. Paustian Development and Characterization of Monoclonal Antibodies and Aptamers against Major Antigens of Mycobacterium avium subsp. paratuberculosis Clin. Vaccine Immunol., May 1, 2007; 14(5): 518 - 526. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |